SC 13G

Company

Enveric Biosciences, Inc.

Filed

February 10, 2021

Accession Number

0001829126-21-000543

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →